Log in to save to my catalogue

10061 Assessing immunogenicity of an Ebola vaccine in humans using a systems biology approach

10061 Assessing immunogenicity of an Ebola vaccine in humans using a systems biology approach

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_670c1c4d9e934e058d932d1c53b2877f

10061 Assessing immunogenicity of an Ebola vaccine in humans using a systems biology approach

About this item

Full title

10061 Assessing immunogenicity of an Ebola vaccine in humans using a systems biology approach

Publisher

Cambridge, UK: Cambridge University Press

Journal title

Journal of clinical and translational science, 2021-03, Vol.5 (s1), p.87-87

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

ABSTRACT IMPACT: Understanding gene expression changes after viral vaccination and booster may help predict vaccine efficacy. OBJECTIVES/GOALS: Utilize a systems biology approach to identify gene expression changes after administration of Zaire Ebola virus glycoprotein expressed in a Chimp Adeno3 vector (ChAd3-EBOZ) and either boosted ˜7 weeks late...

Alternative Titles

Full title

10061 Assessing immunogenicity of an Ebola vaccine in humans using a systems biology approach

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_670c1c4d9e934e058d932d1c53b2877f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_670c1c4d9e934e058d932d1c53b2877f

Other Identifiers

ISSN

2059-8661

E-ISSN

2059-8661

DOI

10.1017/cts.2021.626

How to access this item